ID

13084

Beschreibung

Vector Delivery of the IL-12 Gene in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00406939

Link

https://clinicaltrials.gov/show/NCT00406939

Stichworte

  1. 15.01.16 15.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

15. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostatic Neoplasms NCT00406939

Eligibility Prostatic Neoplasms NCT00406939

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men who have biopsy-proven local recurrence or persistence of cancer in the prostate gland with or without metastatic disease after the hormone therapy, cryosurgery, and/or the completion of definitive radiation therapy for at least one year.
Beschreibung

prostate cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
Beschreibung

patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.

Datentyp

boolean

Alias
UMLS CUI [1]
C0138741
the patient will possess the ability to give informed consent and express a willingness to meet all the expected requirements of the protocol for the duration of the study. (informed consent document).
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients must have adequate baseline organ function as assessed by the following laboratory values before initiating the protocol.
Beschreibung

organ function

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
1. adequate renal function with serum creatinine less than 1.5 mg/dl or creatinine clearance greater than 45 ml/min/m2.
Beschreibung

renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
2. platelet count greater than 100,000 platelets/mm3.
Beschreibung

platelets

Datentyp

boolean

Alias
UMLS CUI [1]
C0005821
3. absolute neutrophil count greater than 1000/mm3.
Beschreibung

absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
4. hemoglobin greater than 8.5 mg/dl
Beschreibung

hemoglobin

Datentyp

boolean

Alias
UMLS CUI [1]
C0019046
5. normal partial thromboplastin time (ptt) and pro-thrombin time (pt).
Beschreibung

ptt and pt

Datentyp

boolean

Alias
UMLS CUI [1]
C0030605
6. bilirubin less than 2.5 mg/dl, sgot and sgpt less than 2.0x normal.
Beschreibung

liver function

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
acute infection: acute infection is defined as any viral, bacterial or fungal infection, which requires specific therapy.
Beschreibung

infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
symptomatic metastasis.
Beschreibung

metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0027627
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months.
Beschreibung

metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671

Ähnliche Modelle

Eligibility Prostatic Neoplasms NCT00406939

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
men who have biopsy-proven local recurrence or persistence of cancer in the prostate gland with or without metastatic disease after the hormone therapy, cryosurgery, and/or the completion of definitive radiation therapy for at least one year.
boolean
C0600139 (UMLS CUI [1])
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
Item
patients must have evidence of biologically active local recurrence of tumor as demonstrated by a rising serum psa level on at least 3 separate occasions at least 2 weeks apart, and that the serum psa be below 50 ng/ml.
boolean
C0138741 (UMLS CUI [1])
informed consent
Item
the patient will possess the ability to give informed consent and express a willingness to meet all the expected requirements of the protocol for the duration of the study. (informed consent document).
boolean
C0021430 (UMLS CUI [1])
organ function
Item
patients must have adequate baseline organ function as assessed by the following laboratory values before initiating the protocol.
boolean
C0678852 (UMLS CUI [1])
renal function
Item
1. adequate renal function with serum creatinine less than 1.5 mg/dl or creatinine clearance greater than 45 ml/min/m2.
boolean
C0201976 (UMLS CUI [1])
platelets
Item
2. platelet count greater than 100,000 platelets/mm3.
boolean
C0005821 (UMLS CUI [1])
absolute neutrophil count
Item
3. absolute neutrophil count greater than 1000/mm3.
boolean
C0948762 (UMLS CUI [1])
hemoglobin
Item
4. hemoglobin greater than 8.5 mg/dl
boolean
C0019046 (UMLS CUI [1])
ptt and pt
Item
5. normal partial thromboplastin time (ptt) and pro-thrombin time (pt).
boolean
C0030605 (UMLS CUI [1])
liver function
Item
6. bilirubin less than 2.5 mg/dl, sgot and sgpt less than 2.0x normal.
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
infection
Item
acute infection: acute infection is defined as any viral, bacterial or fungal infection, which requires specific therapy.
boolean
C0009450 (UMLS CUI [1])
metastasis
Item
symptomatic metastasis.
boolean
C0027627 (UMLS CUI [1])
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months
Item
metastatic lesions in the cns/spinal cord or organs that could become life or function threatening within 3 months.
boolean
C0023671 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video